Pharma’s Next Frontier: Middle East Manufacturing Boom as Saudi Arabia Hosts Inaugural CPHI Event

    Efforts to build a new manufacturing, biomanufacturing and R&D hub in Saudi Arabia and across the wider Middle East are accelerating as...

December 11, 2024 | Wednesday | News
Beyond Cancer Receives Israeli Ministry of Health Approval for Phase 1b Trial of LV UNO in Combination with Anti-PD-1 Therapy

Beyond Cancer, Ltd., a clinical-stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors...

December 04, 2024 | Wednesday | News
NurExone Gains EMA Orphan Designation for ExoPTEN, Advancing Spinal Cord Injury Therapy Across Europe

NurExone Biologic Inc.  a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce that the European Medici...

November 14, 2024 | Thursday | News
Theriva Biologics Named Finalist for Merck KGaA’s EMEA Advance Biotech Grant

Theriva™ Biologics (NYSE American: TOVX), a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer and relate...

November 04, 2024 | Monday | News
Roche Survey Reveals Half of Global Respondents Unaware of HPV’s Link to Cervical Cancer, Urging Immediate Action

Survey findings from over 8,700 people in 12 countries show that half of those polled have inadequate understanding of HPV, with ne...

October 08, 2024 | Tuesday | Reports
Lupin Expands Presence in South Africa with Acquisition of Nine MNI Brands

Global pharma major Lupin Limited (Lupin) announced that its South African subsidiary, Pharma Dynamics, has acquired nine brands along with their associa...

October 07, 2024 | Monday | News
Transforming Vision: Jacqueline Henderson on Johnson & Johnson's Groundbreaking IOL Innovations

As President of EMEA at Vision Johnson & Johnson, Jacqueline Henderson is at the forefront of innovation in ophthalmology, overseeing the development...

October 01, 2024 | Tuesday | Interview
MGI and Dasa Partner to Expand Access to Precision Genomics in Brazil

New technologies will contribute to performing genetic tests to diagnose cancers, rare diseases and other diseases with greater precision, advancing pers...

September 19, 2024 | Thursday | News
BeiGene Secures Israeli Ministry of Health Approval for TEVIMBRA® in Treating Esophageal Squamous Cell Carcinoma

BeiGene, a global oncology company, announced that the Israeli Ministry of Health (IL MOH) has approved TEVIMBRA® (tislelizumab) as monotherapy for t...

September 18, 2024 | Wednesday | News
Sun Pharma and Moebius Medical Receive FDA Fast Track Designation for Osteoarthritis Treatment MM-II

Sun Pharma and Israel-based Moebius Medical Limited announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) t...

September 09, 2024 | Monday | News
Emergent BioSolutions Secures FDA Approval to Expand ACAM2000® Vaccine Indication for Mpox Prevention Amid Global Health Emergency

Emergent BioSolutions announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (s...

August 30, 2024 | Friday | News
Emergent BioSolutions Collaborates with WHO and U.S. Government to Combat Mpox Outbreak in Central Africa

Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease ...

August 20, 2024 | Tuesday | News
Bavarian Nordic Ramps Up Mpox Vaccine Production Amid Africa CDC's Public Health Emergency Declaration

Bavarian Nordic A/S (OMX: BAVA) provides an update on plans for securing supply of vaccines to tackle the current mpox outbreak that the Africa Centers f...

August 19, 2024 | Monday | News
Fapon Biotech Strengthens Global Response to Monkeypox with Innovative Antigen Diagnostics

  Fapon Biotech is a global leader in the In-vitro Diagnostics (IVD) industry, with a steadfast commitment to advancing global health by providing in...

August 19, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close